Cargando…
Development and validation of COVID-19 Impact Scale
BACKGROUND: As the COVID-19 (Coronavirus disease 2019) pandemic is prolonged, psychological responses to the pandemic have changed, and a new scale to reflect these changes needs to be developed. In this study, we attempt to develop and validate the COVID-19 Impact Scale (CIS) to measure the psychol...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978488/ https://www.ncbi.nlm.nih.gov/pubmed/35379349 http://dx.doi.org/10.1186/s40359-022-00793-w |
_version_ | 1784680974197456896 |
---|---|
author | Min, Haewon Kim, Jinwon Moon, Kibum Lee, Seungjin Kim, Jin-young Ko, Young-gun |
author_facet | Min, Haewon Kim, Jinwon Moon, Kibum Lee, Seungjin Kim, Jin-young Ko, Young-gun |
author_sort | Min, Haewon |
collection | PubMed |
description | BACKGROUND: As the COVID-19 (Coronavirus disease 2019) pandemic is prolonged, psychological responses to the pandemic have changed, and a new scale to reflect these changes needs to be developed. In this study, we attempt to develop and validate the COVID-19 Impact Scale (CIS) to measure the psychological stress responses of the COVID-19 pandemic, including emotional responses and difficulty with activities of daily living. METHODS: We recruited 2152 participants. Participants completed the CIS, the Fear of COVID-19 Scale (FCV-19S), and other mental health related measures. The factor structure, reliability, and validity of the CIS were analyzed. In addition, the validity of the scale was confirmed by its relationships to the existing measures assessing fear of COVID-19, depression, anxiety, subjective well-being, and suicidal ideation. RESULTS: Using exploratory factor analysis (N(1) = 1076), we derived a one-factor structure. In confirmatory factor analysis (N(2) = 1076), the one-factor model showed good to excellent fitness. The CIS was positively correlated with depression, anxiety, suicidal ideation, fear of COVID-19 and negatively correlated with subjective well-being. The FCV-19S did not show significant correlations with subjective well-being or suicidal ideation, and FCV-19S’s explanatory powers on depression and anxiety were lower than those of the CIS. CONCLUSIONS: These results support that the CIS is a valid assessment of emotional problems and deterioration of the quality of life caused by the COVID-19 pandemic. Finally, the limitations of this study and future research directions are discussed. |
format | Online Article Text |
id | pubmed-8978488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89784882022-04-04 Development and validation of COVID-19 Impact Scale Min, Haewon Kim, Jinwon Moon, Kibum Lee, Seungjin Kim, Jin-young Ko, Young-gun BMC Psychol Research Article BACKGROUND: As the COVID-19 (Coronavirus disease 2019) pandemic is prolonged, psychological responses to the pandemic have changed, and a new scale to reflect these changes needs to be developed. In this study, we attempt to develop and validate the COVID-19 Impact Scale (CIS) to measure the psychological stress responses of the COVID-19 pandemic, including emotional responses and difficulty with activities of daily living. METHODS: We recruited 2152 participants. Participants completed the CIS, the Fear of COVID-19 Scale (FCV-19S), and other mental health related measures. The factor structure, reliability, and validity of the CIS were analyzed. In addition, the validity of the scale was confirmed by its relationships to the existing measures assessing fear of COVID-19, depression, anxiety, subjective well-being, and suicidal ideation. RESULTS: Using exploratory factor analysis (N(1) = 1076), we derived a one-factor structure. In confirmatory factor analysis (N(2) = 1076), the one-factor model showed good to excellent fitness. The CIS was positively correlated with depression, anxiety, suicidal ideation, fear of COVID-19 and negatively correlated with subjective well-being. The FCV-19S did not show significant correlations with subjective well-being or suicidal ideation, and FCV-19S’s explanatory powers on depression and anxiety were lower than those of the CIS. CONCLUSIONS: These results support that the CIS is a valid assessment of emotional problems and deterioration of the quality of life caused by the COVID-19 pandemic. Finally, the limitations of this study and future research directions are discussed. BioMed Central 2022-04-04 /pmc/articles/PMC8978488/ /pubmed/35379349 http://dx.doi.org/10.1186/s40359-022-00793-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Min, Haewon Kim, Jinwon Moon, Kibum Lee, Seungjin Kim, Jin-young Ko, Young-gun Development and validation of COVID-19 Impact Scale |
title | Development and validation of COVID-19 Impact Scale |
title_full | Development and validation of COVID-19 Impact Scale |
title_fullStr | Development and validation of COVID-19 Impact Scale |
title_full_unstemmed | Development and validation of COVID-19 Impact Scale |
title_short | Development and validation of COVID-19 Impact Scale |
title_sort | development and validation of covid-19 impact scale |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978488/ https://www.ncbi.nlm.nih.gov/pubmed/35379349 http://dx.doi.org/10.1186/s40359-022-00793-w |
work_keys_str_mv | AT minhaewon developmentandvalidationofcovid19impactscale AT kimjinwon developmentandvalidationofcovid19impactscale AT moonkibum developmentandvalidationofcovid19impactscale AT leeseungjin developmentandvalidationofcovid19impactscale AT kimjinyoung developmentandvalidationofcovid19impactscale AT koyounggun developmentandvalidationofcovid19impactscale |